What Sacace Biotechnologies does

Sacace Biotechnologies S.r.l. is a privately held Italian molecular diagnostics company founded in 2001 and headquartered in Como, Italy, that manufactures and sells more than 140 complete diagnostic kits together with proprietary instruments for clinical, veterinary, and food testing laboratories. Its technology platform is built on Real Time PCR (polymerase chain reaction) for the qualitative and quantitative detection of viral and bacterial pathogens and genetic markers, with a proprietary Quantitative Internal Control system using recombinant DNA/RNA structures that carry through extraction to amplification to enable precise viral load calculation. The product portfolio spans three proprietary instruments (SaMag-96 for automated DNA/RNA extraction, Sa2Res as an all-in-one molecular diagnostic platform, and SaCycler for real-time PCR cycling) and a broad reagent menu covering hepatitis (HAV, HBV, HCV, HDV), HIV, HPV, sexually transmitted diseases, herpes, TORCH infections, respiratory infections, tuberculosis, neurological infections, intestinal and parasitic infections, drug resistance, oncology, molecular genetics, periodontitis, and fungal infections, in lyophilized ready-to-use and liquid formats with reported sensitivity of 20 copies/ml for HBV and a linear range of 20 to 50,000,000 IU/ml for HCV.

The company operates a B2B sales-led model targeting molecular diagnostic laboratories, with order placement handled via email ([email protected]) and a mandatory specification of PCR instrument for Real Time PCR kit orders. Distribution is global through direct sales and an international distributor network, with documented presence in Italy, Germany, UAE, Kenya, Singapore, China, USA, and India and a stated reach of 100+ countries. Pricing is in EUR under EXW Como terms with a EUR 300 minimum order value, prepayment or Letter of Credit for orders above EUR 1,000, and current 40% promotional discounts on SaMag-96 (EUR 12,000 promotional vs. EUR 20,000 standard) and Sa2Res (EUR 27,000 promotional vs. EUR 45,000 standard) instruments. Demand generation relies on annual participation in major international trade shows including Medica (Dusseldorf), MedLab (Dubai), AACC (US), Analytica, Arab Health, ECCMID, and Euromedlab. The company has no disclosed external funding, no parent company, and no documented leadership team, partnerships beyond a banking relationship with Intesa Sanpaolo, regulatory certifications, patents, or M&A activity.

Name

Sacace Biotechnologies

Legal name

Sacace Biotechnologies S.r.l.

Website

https://sacace.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Sacace Biotechnologies is a privately held Italian molecular diagnostics company founded in 2001 that manufactures over 140 Real Time PCR reagent kits and proprietary extraction and amplification instruments for clinical, veterinary, and food testing laboratories worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Como

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Real Time PCR Reagent Kits: Sale of lyophilized and liquid format PCR reagent kits for detection of various pathogens. Kits are sold in standard pack sizes (50, 96, 100, 120 tests) with product codes for ordering.
2. Diagnostic Instruments: Sale of molecular diagnostic instruments including SaMag-96 (automatic DNA/RNA extraction) and Sa2Res (All-in-One Molecular Diagnostic Instrument). Instruments sold with pricing in EUR.
3. International Distribution: Products sold internationally with EXW price terms from Como, Italy. Orders require minimum EUR 300.00 order value with 3-5 weeks delivery time.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Sacace Biotechnologies manufactures and sells more than 140 complete kits for human, veterinary, and food molecular diagnostics, leveraging Real Time PCR technology. Its portfolio includes reagent kits for detection and quantification of viral, bacterial, and parasitic pathogens as well as genetic markers, complemented by proprietary instruments for nucleic acid extraction and PCR amplification (SaMag-96, Sa2Res, SaCycler). Kits are supplied in lyophilized ready-to-use and liquid formats with quantitative internal controls and are sold to molecular diagnostic laboratories worldwide.

Product overview

Sacace Biotechnologies is a molecular diagnostics company offering complete reagent kits and instruments for the molecular diagnostic laboratory since 2001. The product portfolio includes three main instrument lines (SaMag-96 for automated DNA/RNA extraction, Sa2Res and SaCycler for real-time PCR), along with an extensive range of Real Time PCR reagent kits covering infectious diseases including Hepatitis (HAV, HBV, HCV, HDV, HGV), HIV, HPV, sexually transmitted diseases, herpes viruses, TORCH infections, respiratory infections, tuberculosis, neurological infections, intestinal and parasitic infections, dangerous infections, oncological diseases, drug resistance, molecular genetics, periodontitis, and fungal infections. The reagents come in both lyophilized (ready-to-use) and liquid formats, with quantitative and qualitative detection options for various pathogens.

Differentiator

Problem solved

Functional benefit

Products and services

• SaMag-96 Automatic DNA/RNA Extraction Instrument Automated nucleic acid extraction instrument (96-well) for molecular diagnostic laboratories, providing reliable and fast automated DNA/RNA extraction for downstream Real Time PCR testing. Priced at EUR 20,000 standard, currently EUR 12,000 under a 40% promotional discount.
• Sa2Res All-in-One Molecular Diagnostic Instrument Integrated molecular diagnostic instrument for molecular testing workflows, sold alongside Sacace reagent kits with standard price EUR 45,000 and promotional price EUR 27,000 (40% off).
• SaCycler Real-Time PCR Cycler Real-time PCR cycler instrument for molecular diagnostics, supporting Sacace's Real-TM reagent kits and third-party PCR assays.
• COVID-19 SARS-Cov-2 Real-TM PCR Kit Multi-target Real Time PCR kit for qualitative detection of SARS-CoV-2 RNA in clinical samples, detecting two different specific genomic regions of the virus.
• COVID-19 SARS-Cov-2 Variant Typing Real-TM Kit Multiplex Real Time PCR kit for qualitative detection and differentiation of SARS-CoV-2 spike-protein mutations (HV 69-70 DEL, N501Y, E484K, K417N) to identify Omicron, UK, South African, and Brazilian variants in clinical samples.
• Hepatitis Virus PCR Kit Line (HAV, HBV, HCV, HDV, HGV detection, quantification, and genotyping) Comprehensive Real Time PCR kit line covering hepatitis A, B, C, D, and G viruses for qualitative detection, quantitative viral load measurement, and genotyping (HBV genotypes A–D; HCV genotypes 1, 2, 3, 4, 5a, 6 plus IL28B polymorphism testing). Kits are available in lyophilized and liquid formats with internal controls.
• HIV PCR Kit Line (HIV-1 quantification and qualitative detection, HIV proviral DNA, HLA B*57:01 genotyping) Real Time PCR kits for detection, quantification, and qualification of Human Immunodeficiency Virus (HIV-1 RNA, HIV-1 DNA, HIV proviral DNA) and for pharmacogenetic HLA-B*57:01 allele detection, supporting early detection in window period, infant diagnostics, therapy monitoring, and abacavir hypersensitivity assessment.
• Tuberculosis, Antibiotic Resistance, and Other Infectious Disease PCR Kits Real Time PCR kits covering tuberculosis drug resistance (MTB MDR for isoniazid and rifampicin resistance), bacterial antibiotic resistance genes, Clostridium difficile detection, and Chikungunya virus RNA detection, supplementing the broader infectious-disease catalog (HPV, sexually transmitted diseases, herpes, TORCH, respiratory, neurological, intestinal/parasitic, dangerous infections, oncology, drug resistance, molecular genetics, periodontitis, and fungal infections).

Quantifiable outcome

• HBV detection sensitivity of 20 copies/ml when used with Magno-Virus extraction kit
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Qiagen: Global molecular diagnostics and sample-technology leader offering PCR reagents (artus, QIAamp) and instruments (QIAcube, Rotor-Gene). Directly comparable to Sacace on the PCR kit side and far broader in scope, but competes in the same clinical lab channel.
• bioMérieux: Major IVD company with bioMérieux Molecular (formerly BioFire) and legacy ARGENE PCR kits for infectious diseases. Overlaps with Sacace's hepatitis/HIV/STD menus and competes for the same molecular diagnostic laboratory customer.
• Roche Diagnostics: Operates the cobas line of real-time PCR instruments and viral load assays (HBV, HCV, HIV). Competes head-on with Sacace in hepatitis and HIV viral load testing for medium-sized labs, but offers a far larger menu and automated workflows.
• Abbott Molecular: Provides the m2000 system and RealTime PCR assays (HBV, HCV, HIV-1) for clinical labs. Directly competes with Sacace in viral-load testing and offers extensive instrument-reagent bundling programmes aimed at mid-volume labs.
• Cepheid (Danaher): Operates the GeneXpert fully-automated real-time PCR system with Xpert assays for HCV, HBV, HIV, CT/NG, MTB. Dominates large/mid lab segments and increasingly encroaches on small-lab workflows, raising competitive intensity for Sacace's core lab customer.

Direct peers

• ELITech Group: Europe-based developer and manufacturer of real-time PCR kits (ELITe InGenius instrument, MGB Kits) for infectious disease diagnostics. Closely mirrors Sacace's product mix in hepatitis/HIV/STD kits and mid-sized lab targeting, making it a direct competitor.
• GeneProof: Czech manufacturer of broad-portfolio real-time PCR kits for infectious diseases (hepatitis, HIV, respiratory, STDs) and the croBEE instrument. Operates in almost the same niche as Sacace, offering lyophilized kits to small/medium molecular labs across Europe, MENA and APAC.
• Vircell: Spanish molecular diagnostics specialist with PCR kits for hepatitis, HIV, respiratory and transplant pathogens. Comparable mid-sized company competing for the same European/Spanish-language molecular lab accounts.

Regional players

• AB Analitica: Italy-based molecular diagnostics manufacturer offering real-time PCR kits for infectious diseases with strong distribution in Italian and select international markets. Italian regional peer of Sacace, overlapping heavily in hepatitis and STI menus.

Emerging players

• Bioneer: Korean molecular diagnostics company offering AccuPower real-time PCR kits and ExiStation instruments for hepatitis, HPV, sexually transmitted infections and respiratory pathogens. Comparable kit-and-instrument two-sided model with similar reagent-only positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sacace-biotechnologies-srl

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sacace Biotechnologies